Lupin completes acquisition of VISUfarma
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
First of its kind screening for Glaucoma at grass root level over 10k screened already
The company is moving towards complex and more differentiated products
Subscribe To Our Newsletter & Stay Updated